Wall Street Breakfast
Netflix lights up Christmas with NFL ratings win
![](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/9d03f5aa0b4133bdd516ba1836a0e249.jpg)
Netflix (NFLX) dazzles with record-setting ratings for Christmas NFL games. (00:24) Rigetti (RGTI) leads quantum stocks higher as year-end surge continues. (1:59) Mortgage rates up for the second straight week. (03:20)
Episode transcripts seekingalpha.com/wsb.
Show links:
Biggest stock movers Friday: SES, ABAT
Top dividend picks for 2025 according to Seeking Alpha’s Quant metrics
With the new year upon us, a look back at Wall Street's Santa rallies since 2000
Elon Musk says he prefers Lilly’s Mounjaro over Novo’s Ozempic
Find out more about Seeking Alpha's Virtual Analyst Reports here.
Episode transcripts seekingalpha.com/wsb.
Show links:
Biggest stock movers Friday: SES, ABAT
Top dividend picks for 2025 according to Seeking Alpha’s Quant metrics
With the new year upon us, a look back at Wall Street's Santa rallies since 2000
Elon Musk says he prefers Lilly’s Mounjaro over Novo’s Ozempic
Find out more about Seeking Alpha's Virtual Analyst Reports here.
- Broadcast on:
- 27 Dec 2024
Netflix (NFLX) dazzles with record-setting ratings for Christmas NFL games. (00:24) Rigetti (RGTI) leads quantum stocks higher as year-end surge continues. (1:59) Mortgage rates up for the second straight week. (03:20)
Episode transcripts seekingalpha.com/wsb.
Show links:
Biggest stock movers Friday: SES, ABAT
Top dividend picks for 2025 according to Seeking Alpha’s Quant metrics
With the new year upon us, a look back at Wall Street's Santa rallies since 2000
Elon Musk says he prefers Lilly’s Mounjaro over Novo’s Ozempic
Find out more about Seeking Alpha's Virtual Analyst Reports here.
Episode transcripts seekingalpha.com/wsb.
Show links:
Biggest stock movers Friday: SES, ABAT
Top dividend picks for 2025 according to Seeking Alpha’s Quant metrics
With the new year upon us, a look back at Wall Street's Santa rallies since 2000
Elon Musk says he prefers Lilly’s Mounjaro over Novo’s Ozempic
Find out more about Seeking Alpha's Virtual Analyst Reports here.